Gastric & Breast Cancer e-journal
DOI: 10.2122/gbc.2012.0252
NEWS & VIEWS
|
Advances and limitations with multimodal treatment of Colorectal cancer liver metastases.
|
George Glantzounis, MD, PhD.
|
Affiliation: George Glantzounis, Assistant Professor of Surgery, Department of Surgery, University Hospital of Ioannina, Ioannina, TK 45110, Greece.
E-mail: gglantzounis@hotmail.com |
Since there is no abstract available we provide the first paragraph.
Although surgery resulting in complete resection of liver metastases (R0) from primary colorectal cancer has been the standard of care, timing of systemic chemotherapy (before or after surgery) and targeted therapy with cetuximab or panitumumab remains challenging. The recent advances with minimally invasive resection of colorectal cancer liver metastases and systemic treatment are discussed.
(Citation: Gastric & Breast Cancer 2012; 10(4): 239-241)
|
|
| You can have an online full-text access and a PDF of this article: |
- Either purchase this paper for €35 EUR. Please, click here
|
|
- Or through one year subscription PayPal
|
|
